ES2492537T3 - Composiciones que comprenden florfenicol o un compuesto relacionado estructuralmente para tratar infección en ganado bovino y porcino - Google Patents

Composiciones que comprenden florfenicol o un compuesto relacionado estructuralmente para tratar infección en ganado bovino y porcino Download PDF

Info

Publication number
ES2492537T3
ES2492537T3 ES04753639.6T ES04753639T ES2492537T3 ES 2492537 T3 ES2492537 T3 ES 2492537T3 ES 04753639 T ES04753639 T ES 04753639T ES 2492537 T3 ES2492537 T3 ES 2492537T3
Authority
ES
Spain
Prior art keywords
group
ethyl
methyl
phenyl
florfenicol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES04753639.6T
Other languages
English (en)
Inventor
Keith A. Freehauf
Allan J. Weingarten
Robert D. Simmons
Kanwal Jit Varma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Application granted granted Critical
Publication of ES2492537T3 publication Critical patent/ES2492537T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Una composición para el tratamiento de infección microbiana en un animal que comprende: a) sólo un principio activo, constituido por el antibiótico de la Fórmula I: en la que R es un miembro seleccionado del grupo que consiste en metilo, etilo o un derivado halogenado de metilo o etilo, dihalodeuteriometilo, 1-halo-1-deuterioetilo, 1,2-dihalo-1-deuterioetilo, azidometilo y metilsulfonilmetilo; X y X' son un miembro seleccionado independientemente del grupo que consiste en NO2, SO2R1, SOR1, SR1, SONH2, SO2NH2, SONHR1, SO2NHR1, COR1, OR1, R1, CN, halógeno, hidrógeno, fenilo y fenilo mono-, di- o trisustituido con halógeno, NO2, R1, PO2R1, CONHR1, NHR1, NR1R2, CONR1R2, OCOR1 u OR1, en el que R1 y R2 son un miembro seleccionado independientemente del grupo que consiste en metilo, etilo, n-propilo, isopropilbutilo, t-butilo, isobutilo y fenilo; y Z es hidrógeno o un grupo acilo de un ácido hidrocarbonocarboxílico que tiene hasta 16 átomos de carbono o un grupo acilo de un ácido aminohidrocarbonocarboxílico que tiene hasta 12 átomos de carbono; y las sales farmacéuticamente aceptables de dichos grupos acilo; y b) el vehículo triacetina. c) la 2-pirrolidona

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9

Claims (1)

  1. imagen1
    imagen2
ES04753639.6T 2003-05-29 2004-05-28 Composiciones que comprenden florfenicol o un compuesto relacionado estructuralmente para tratar infección en ganado bovino y porcino Expired - Lifetime ES2492537T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47429403P 2003-05-29 2003-05-29
US474294P 2003-05-29
PCT/US2004/016841 WO2004110494A1 (en) 2003-05-29 2004-05-28 Compositions for treating infection in cattle and swine

Publications (1)

Publication Number Publication Date
ES2492537T3 true ES2492537T3 (es) 2014-09-09

Family

ID=33551488

Family Applications (1)

Application Number Title Priority Date Filing Date
ES04753639.6T Expired - Lifetime ES2492537T3 (es) 2003-05-29 2004-05-28 Composiciones que comprenden florfenicol o un compuesto relacionado estructuralmente para tratar infección en ganado bovino y porcino

Country Status (24)

Country Link
US (2) US8034845B2 (es)
EP (1) EP1626739B1 (es)
JP (2) JP4728244B2 (es)
KR (1) KR101132079B1 (es)
CN (2) CN102342925A (es)
AR (2) AR044437A1 (es)
AU (2) AU2004247053B2 (es)
BR (1) BRPI0410795B1 (es)
CA (1) CA2526202C (es)
CL (1) CL2004001293A1 (es)
EC (1) ECSP056189A (es)
ES (1) ES2492537T3 (es)
IL (1) IL172224A0 (es)
MX (1) MXPA05012827A (es)
MY (1) MY146351A (es)
NO (1) NO20056223L (es)
NZ (1) NZ543594A (es)
PE (1) PE20050386A1 (es)
PL (2) PL380481A1 (es)
RU (1) RU2359659C2 (es)
TW (1) TW200505425A (es)
UA (1) UA81676C2 (es)
WO (1) WO2004110494A1 (es)
ZA (1) ZA200509544B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11090444B2 (en) 2018-06-15 2021-08-17 James T. Doubet Syringe adapter for medication
US11097058B2 (en) 2018-06-15 2021-08-24 James T. Doubet Syringe adapter for medication
US10709850B2 (en) 2018-06-15 2020-07-14 James T. Doubet Syringe adapter for medication
US11337894B2 (en) 2018-06-15 2022-05-24 James T. Doubet Syringe adapter for animal medication
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
UA82359C2 (uk) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин
CL2004001293A1 (es) 2003-05-29 2005-05-06 Schering Plough Ltd Composicion farmaceutica que comprende compuestos antibacterianos como florfenicol, tiamfenicol, cloramfenicol en combinacion con al menos un portador seleccionado de triacetina, dimetilacetamida o una mezcla de ellas; y su uso en el tratamiento de u
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
PT1830885E (pt) * 2004-12-21 2008-12-22 Intervet Int Bv Composição veterinária injectável
GB0501220D0 (en) * 2005-01-21 2005-03-02 Norbrook Lab Ltd Anthelmintic composition
KR101544584B1 (ko) * 2006-11-01 2015-08-13 프로노바 바이오파마 너지 에이에스 오메가-3 지질 화합물
JP5552313B2 (ja) * 2006-11-01 2014-07-16 プロノヴァ・バイオファーマ・ノルゲ・アーエス 脂質化合物
CN101600686A (zh) * 2006-12-13 2009-12-09 先灵-普劳有限公司 氯霉素、甲砜霉素及其类似物的水溶性前药
KR20090090387A (ko) * 2006-12-19 2009-08-25 쉐링-프라우 리미티드 음료수 시스템 내에 추가하기 위한 플로르페니콜의 비등성 제형
PE20091171A1 (es) * 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol
FR2925334A1 (fr) * 2007-12-21 2009-06-26 Ceva Sante Animale Sa Nouvelles compositions antibacteriennes
CA2732017A1 (en) * 2008-07-30 2010-02-04 Intervet International B.V. Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
EP2488145B1 (en) 2009-10-12 2024-04-24 Boehringer Ingelheim Vetmedica GmbH Containers for compositions comprising meloxicam
KR101140167B1 (ko) * 2009-11-04 2012-04-24 최기동 동물용 의약 조성물 및 이를 포함하는 동물용 의약품
BRPI1002021A2 (pt) 2010-01-21 2012-05-22 Nanocore Biotecnologia S A composições farmacêuticas para tratamento de infecções bacterianas
BRPI1002023A2 (pt) 2010-03-01 2011-10-25 Nanocore Biotecnologia S A forma farmacêutica sólida de dissolução rápida para tratamento de infecções bacterianas
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
HRP20190779T1 (hr) * 2010-12-22 2019-06-28 Bayer Intellectual Property Gmbh Pojačani imunosni odgovor kod goveda
CA2893072C (en) * 2012-11-29 2023-10-03 Cornell University Vaccine for intrauterine disease
EA028381B1 (ru) * 2014-08-08 2017-11-30 Александр Петрович Мерабишвили Фармацевтический препарат ветеринарного назначения
EA028412B9 (ru) * 2014-08-08 2018-03-30 Александр Петрович Мерабишвили Фармацевтический препарат ветеринарного назначения
RU2563826C1 (ru) * 2014-08-21 2015-09-20 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Инъекционная антибактериальная фармацевтическая композиция
JP2018518511A (ja) * 2015-06-26 2018-07-12 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ａｎｉｍａｌ Ｈｅａｌｔｈ Ｇｍｂｈ 細胞質ｄｎａ監視分子の調節方法
US20180187263A1 (en) * 2017-01-05 2018-07-05 Iowa State University Research Foundation, Inc. Kits for diagnostic detection and prevention of feedlot bovine respiratory disease
USD890925S1 (en) 2018-06-15 2020-07-21 James T. Doubet Syringe adapter for medication
US20190388625A1 (en) 2018-06-15 2019-12-26 James T. Doubet Syringe adapter for medication
WO2020002234A1 (en) * 2018-06-25 2020-01-02 Intervet International B.V. Compounds useful for the treatment of infection with mannheimia haemolytica or histophilus somni

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2671748A (en) * 1950-05-18 1954-03-09 Parke Davis & Co Composition of matter
ES8104203A1 (es) 1979-02-05 1981-04-16 Schering Corp Un procedimiento para la preparacion de un compuesto d-(treo-1-aril-2-acilamido-3-fluor-1-propanol
US4235892A (en) * 1979-02-05 1980-11-25 Schering Corporation, Patent Dept. 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
US5105009A (en) 1983-06-02 1992-04-14 Zambon S.P.A. Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5663361A (en) 1996-08-19 1997-09-02 Schering Corporation Process for preparing intermediates to florfenicol
PT949905E (pt) * 1996-12-20 2001-12-28 Alza Corp Composicao de gel injectavel de efeito retardado e processo para a sua preparacao
IL132676A0 (en) 1997-05-06 2001-03-19 Norbrook Lab Ltd Improvements in or relating to long-acting antimicrobials
CA2211949A1 (en) * 1997-07-21 1999-01-29 David Farley Johnson Nonaqueous compositions for parenteral administration
JP2003512290A (ja) 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
CN1205921C (zh) * 1997-12-03 2005-06-15 麦克公司 含有氢化蓖麻油的长效注射制剂
US6136838A (en) 1998-03-19 2000-10-24 Merck & Co., Inc. Sulfurpentafluorophenylpyrazoles for controlling ectoparasitic infestations
ES2359973T3 (es) * 1998-03-19 2011-05-30 MERCK SHARP &amp; DOHME CORP. Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
US6174540B1 (en) * 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
JP2001226257A (ja) * 2000-02-17 2001-08-21 Material Eng Tech Lab Inc 溶液製剤
US6787568B1 (en) 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
US20020102280A1 (en) * 2000-11-29 2002-08-01 Anderson David M. Solvent systems for pharmaceutical agents
KR20040091698A (ko) 2002-03-08 2004-10-28 쉐링-플라우 리미티드. 신규한 플로르페니콜형 항생제
US6790867B2 (en) 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
CN1507858A (zh) 2002-12-19 2004-06-30 王玉万 含氟化氯霉素的兽用液体制剂
UA82359C2 (uk) 2003-04-03 2008-04-10 Schering Plough Ltd Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин
CL2004001293A1 (es) 2003-05-29 2005-05-06 Schering Plough Ltd Composicion farmaceutica que comprende compuestos antibacterianos como florfenicol, tiamfenicol, cloramfenicol en combinacion con al menos un portador seleccionado de triacetina, dimetilacetamida o una mezcla de ellas; y su uso en el tratamiento de u
EP1626980A4 (en) * 2003-05-29 2007-07-04 Univ Washington NEUROACTIVE 13,24-CYCLO-18,21-DINORCHOLANES AND STRUCTURELY RELATED PENTACYCLIC STEROIDS
JP4719160B2 (ja) 2003-12-23 2011-07-06 シェーリング−プラウ・リミテッド 改善された水溶性を有するフロルフェニコールプロドラッグ
US7361689B2 (en) 2003-12-31 2008-04-22 Schering-Plough Animal Health Corporation Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof
PT1830885E (pt) 2004-12-21 2008-12-22 Intervet Int Bv Composição veterinária injectável
MX2008003188A (es) 2005-09-07 2008-03-18 Schering Plough Ltd Procedimiento para la preparacion de compuestos ester oxazolidina y su conversion a florfenicol.
US8119667B2 (en) 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
CN101600686A (zh) 2006-12-13 2009-12-09 先灵-普劳有限公司 氯霉素、甲砜霉素及其类似物的水溶性前药
MX2009006282A (es) 2006-12-13 2009-06-23 Schering Plough Ltd Profarmacos solubles en agua de florfenicol y sus analogos.
US20080153906A1 (en) 2006-12-13 2008-06-26 Celly Chander S Water-Soluble Phenicol Prodrugs in a Lipophilic Vehicle System
KR20090090387A (ko) 2006-12-19 2009-08-25 쉐링-프라우 리미티드 음료수 시스템 내에 추가하기 위한 플로르페니콜의 비등성 제형
RU2009143731A (ru) 2007-04-27 2011-06-10 Шеринг-Плоу Лтд. (CH) Соединения и способы улучшения растворимости флорфеникола и структурно родственных антибиотиков с помощью циклодекстринов
MX2009013016A (es) 2007-05-30 2010-02-17 Schering Plough Ltd Un procedimiento para preparar compuestos de aminodiol oxazolina-protegidos utiles como intermediarios para florfenicol.
EP2173726A2 (en) 2007-07-25 2010-04-14 Intervet International B.V. Process for preparing oxazolidine- and oxazolidinone-aminodiols
WO2009061780A1 (en) 2007-11-09 2009-05-14 Schering-Plough Limited Fast release solid formulation, preparation and use thereof
PE20091171A1 (es) 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol

Also Published As

Publication number Publication date
EP1626739B1 (en) 2014-05-21
KR101132079B1 (ko) 2012-04-20
UA81676C2 (ru) 2008-01-25
ECSP056189A (es) 2006-08-30
PE20050386A1 (es) 2005-06-23
AR044437A1 (es) 2005-09-14
RU2005141127A (ru) 2006-06-10
JP2007269801A (ja) 2007-10-18
AU2010235885A1 (en) 2010-11-11
ZA200509544B (en) 2007-01-31
IL172224A0 (en) 2009-02-11
CL2004001293A1 (es) 2005-05-06
AR101380A2 (es) 2016-12-14
BRPI0410795A (pt) 2006-06-20
BRPI0410795B1 (pt) 2017-12-19
US8034845B2 (en) 2011-10-11
NO20056223L (no) 2005-12-29
MXPA05012827A (es) 2006-02-13
US20040242546A1 (en) 2004-12-02
CA2526202C (en) 2012-07-03
AU2004247053B2 (en) 2010-11-11
CN102342925A (zh) 2012-02-08
TW200505425A (en) 2005-02-16
CN1795013A (zh) 2006-06-28
US9084719B2 (en) 2015-07-21
JP2006528705A (ja) 2006-12-21
MY146351A (en) 2012-08-15
CA2526202A1 (en) 2004-12-23
US20120077764A1 (en) 2012-03-29
KR20060016093A (ko) 2006-02-21
PL1626739T3 (pl) 2014-10-31
PL380481A1 (pl) 2007-02-05
RU2359659C2 (ru) 2009-06-27
NZ543594A (en) 2010-03-26
WO2004110494A1 (en) 2004-12-23
JP4728244B2 (ja) 2011-07-20
EP1626739A1 (en) 2006-02-22
AU2004247053A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
ES2492537T3 (es) Composiciones que comprenden florfenicol o un compuesto relacionado estructuralmente para tratar infección en ganado bovino y porcino
AR039826A1 (es) Composiciones y metodo para el tratamiento de infeccion en ganado vacuno y porcino
RU2397168C2 (ru) Производные тиофена в качестве ингибиторов снк 1
ES2540853T3 (es) Sales de dicetopiperazina para la administración de fármacos
PA8520301A1 (es) Derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal
ATE58059T1 (de) Arylcyclobutylalkylamin-derivat zur behandlung von morbus parkinson.
AR060150A1 (es) Heteropentaciclos activos como inhibidores de quinasas, y su uso para tratar trastornos de la proliferacion celular
AR035567A1 (es) Composiciones que comprenden bloqueadores de transferencia de celula renal l-dopa para el tratamiento de la enfermedad de parkinson
JP7305620B2 (ja) 動物寄生虫（ａｎｉｍａｌ ｐａｒａｓｉｔｅｓ）の防除および予防のための局所投与製剤
ECSP045017A (es) Cristales de derivado de hidroxinorefedrina
JP2022521339A (ja) グラム陽性菌に対して向上された抗菌活性を提供する組成物およびその使用
ECSP056074A (es) Composiciones y método para tratar las infecciones microbianas y parasitarias en el ganado y otros animales
AR029412A1 (es) Forma cristalina
AR007021A1 (es) Derivados de 3-descladinosa-2,3-anhidroeritromicina, procedimientos para su preparacion, compuestos para su exclusivo uso en dichos procedimientosy procedimiento para su preparacion, una composicion farmaceutica para tratar infecciones bacterianas y el uso de estos compuestos para preparar medicamentos
JP2007534743A5 (es)
RU2008115239A (ru) 7-[2-[4-(6-фтор-3-метил-1, 2-бензизоксазол-5-ил)-1-пиперазинил]этил]-2-(пропинил)-7h-пиразоло-[4,3-е]-[1,2,4]-триазоло-[1,5-с]пиримидин-5-амин
JP2024073470A5 (es)
JP2007505105A5 (es)
BRPI0616659A8 (pt) droga terapêutica antituberculose, medicamento, e, kit para o tratamento de tuberculose
MX2022011240A (es) Azálidos de urea inmunomoduladores.
RU2008100220A (ru) Применение делмопинола для лечения воспаления сальных желез
PE20020431A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido
AR071928A1 (es) El uso de compuestos de 6-halogeno-(1,2,4)-triazolo-(1,5-a)-pirimidina para combatir plagas en y sobre animales
AR037543A1 (es) Metodo para la terapia del cancer y composicion farmaceutica
ATE430134T1 (de) Chinolinderivate, syntheseverfahren und diese derivate enthaltende medikamente